• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用单模型预测控制对 1 型糖尿病进行血糖调节和胰岛素、胰高血糖素输注控制。

Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus.

机构信息

Department of Instrumentation and Control, Manipal Academy of Higher Education, Manipal Institute of Technology, Manipal, India.

Department of Medicine, Manipal Academy of Higher Education, Kasturba Medical College, Manipal, India.

出版信息

IET Syst Biol. 2020 Jun;14(3):133-146. doi: 10.1049/iet-syb.2019.0101.

DOI:10.1049/iet-syb.2019.0101
PMID:32406378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8687336/
Abstract

This study elaborates on the design of artificial pancreas using model predictive control algorithm for a comprehensive physiological model such as the Sorensen model, which regulates the blood glucose and can have a longer control time in normal glycaemic region. The main objective of the proposed algorithm is to eliminate the risk of hyper and hypoglycaemia and have a precise infusion of hormones: insulin and glucagon. A single model predictive controller is developed to control the bihormones, insulin, and glucagon for such a development unmeasured disturbance is considered for a random time. The simulation result for the proposed algorithm performed good regulation lowering the hypoglycaemia risk and maintaining the glucose level within the normal glycaemic range. To validate the performance of the tracking of output and setpoint, average tracking error is used and 4.4 mg/dl results are obtained while compared with standard value (14.3 mg/dl).

摘要

本研究详细阐述了使用模型预测控制算法设计人工胰腺,该算法针对 Sorensen 等综合生理模型进行了优化,可以在正常血糖区域实现更长时间的控制。该算法的主要目标是消除高血糖和低血糖的风险,并精确输注激素:胰岛素和胰高血糖素。我们开发了一种单一的模型预测控制器来控制这两种激素,胰岛素和胰高血糖素,同时考虑到未测量的干扰会在随机时间发生。所提出的算法的仿真结果表现良好,可以降低低血糖风险,并使血糖水平维持在正常血糖范围内。为了验证输出和设定值跟踪的性能,我们使用了平均跟踪误差,结果为 4.4mg/dl,与标准值(14.3mg/dl)相比。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d1bfe1120787/SYB2-14-133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/7caf1208d9bf/SYB2-14-133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/52bb3917c13e/SYB2-14-133-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d3c8e44c3c97/SYB2-14-133-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/8276891f6f9b/SYB2-14-133-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/a1d27e87d529/SYB2-14-133-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/eecfa58c1b2d/SYB2-14-133-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/8f5470f892ca/SYB2-14-133-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/835bcde64bb5/SYB2-14-133-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/68e4bbcf110e/SYB2-14-133-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d94158fb2af6/SYB2-14-133-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/15563c80ccd8/SYB2-14-133-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/f1e3362b441c/SYB2-14-133-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/43c52fabcf50/SYB2-14-133-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/e3fff4889935/SYB2-14-133-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/4ccadfe4f7cf/SYB2-14-133-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/cb3e7688633c/SYB2-14-133-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d1bfe1120787/SYB2-14-133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/7caf1208d9bf/SYB2-14-133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/52bb3917c13e/SYB2-14-133-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d3c8e44c3c97/SYB2-14-133-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/8276891f6f9b/SYB2-14-133-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/a1d27e87d529/SYB2-14-133-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/eecfa58c1b2d/SYB2-14-133-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/8f5470f892ca/SYB2-14-133-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/835bcde64bb5/SYB2-14-133-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/68e4bbcf110e/SYB2-14-133-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d94158fb2af6/SYB2-14-133-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/15563c80ccd8/SYB2-14-133-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/f1e3362b441c/SYB2-14-133-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/43c52fabcf50/SYB2-14-133-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/e3fff4889935/SYB2-14-133-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/4ccadfe4f7cf/SYB2-14-133-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/cb3e7688633c/SYB2-14-133-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a7/8687336/d1bfe1120787/SYB2-14-133-g002.jpg

相似文献

1
Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus.采用单模型预测控制对 1 型糖尿病进行血糖调节和胰岛素、胰高血糖素输注控制。
IET Syst Biol. 2020 Jun;14(3):133-146. doi: 10.1049/iet-syb.2019.0101.
2
Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm.基于 MPC 算法的双激素血糖治疗设计及与单激素治疗的比较。
IET Syst Biol. 2020 Oct;14(5):241-251. doi: 10.1049/iet-syb.2020.0053.
3
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.双激素人工胰腺、单激素人工胰腺与常规胰岛素泵治疗对 1 型糖尿病患者血糖控制的比较:一项开放标签随机对照交叉试验。
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26. doi: 10.1016/S2213-8587(14)70226-8. Epub 2014 Nov 27.
4
Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.基于切换控制和动态R参数的双激素人工胰腺系统的经济模型预测控制
J Diabetes Sci Technol. 2017 Nov;11(6):1112-1123. doi: 10.1177/1932296817721519. Epub 2017 Jul 21.
5
A composite model of glucagon-glucose dynamics for in silico testing of bihormonal glucose controllers.用于双激素血糖控制器计算机模拟测试的胰高血糖素-葡萄糖动力学复合模型。
J Diabetes Sci Technol. 2013 Jul 1;7(4):941-51. doi: 10.1177/193229681300700416.
6
A model-based algorithm for blood glucose control in type I diabetic patients.一种用于 I 型糖尿病患者血糖控制的基于模型的算法。
IEEE Trans Biomed Eng. 1999 Feb;46(2):148-57. doi: 10.1109/10.740877.
7
A bio-inspired glucose controller based on pancreatic β-cell physiology.一种基于胰腺β细胞生理学的仿生葡萄糖控制器。
J Diabetes Sci Technol. 2012 May 1;6(3):606-16. doi: 10.1177/193229681200600316.
8
Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.持续生理性高胰岛素血症对正常人和糖尿病患者葡萄糖动力学及反调节激素的影响。
J Clin Invest. 1979 May;63(5):849-57. doi: 10.1172/JCI109384.
9
Efficacy determinants of subcutaneous microdose glucagon during closed-loop control.闭环控制期间皮下微剂量胰高血糖素的疗效决定因素
J Diabetes Sci Technol. 2010 Nov 1;4(6):1288-304. doi: 10.1177/193229681000400602.
10
Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.葡萄糖反应性胰岛素和胰高血糖素递送(双激素人工胰腺)在 1 型糖尿病成人中的随机交叉对照试验。
CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.

引用本文的文献

1
Event-triggered smart dual hormone artificial pancreas for patient-specific drug delivery.用于个性化给药的事件触发型智能双激素人工胰腺。
Sci Rep. 2025 Sep 1;15(1):32045. doi: 10.1038/s41598-025-18085-9.
2
Model predictive control optimisation using the metaheuristic optimisation for blood pressure control.使用元启发式优化进行血压控制的模型预测控制优化。
IET Syst Biol. 2021 Apr;15(2):41-52. doi: 10.1049/syb2.12012. Epub 2021 Feb 14.
3
Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm.

本文引用的文献

1
Advances in artificial pancreas systems.人工胰腺系统的进展。
Sci Transl Med. 2019 Mar 20;11(484). doi: 10.1126/scitranslmed.aaw4949.
2
Current Diabetes Technology: Striving for the Artificial Pancreas.当前糖尿病技术:迈向人工胰腺的征程
Diagnostics (Basel). 2019 Mar 15;9(1):31. doi: 10.3390/diagnostics9010031.
3
Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.连续血糖监测:基层医疗从业者简要综述
基于 MPC 算法的双激素血糖治疗设计及与单激素治疗的比较。
IET Syst Biol. 2020 Oct;14(5):241-251. doi: 10.1049/iet-syb.2020.0053.
Adv Ther. 2019 Mar;36(3):579-596. doi: 10.1007/s12325-019-0870-x. Epub 2019 Jan 18.
4
Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?1 型糖尿病的人工胰腺(闭环系统)有效吗?
Diabet Med. 2019 Mar;36(3):279-286. doi: 10.1111/dme.13816. Epub 2018 Oct 16.
5
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.人工胰腺治疗 1 型糖尿病门诊患者:系统评价和荟萃分析。
BMJ. 2018 Apr 18;361:k1310. doi: 10.1136/bmj.k1310.
6
Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System.多变量人工胰腺系统中未宣布的进餐自动检测和估计。
Diabetes Technol Ther. 2018 Mar;20(3):235-246. doi: 10.1089/dia.2017.0364. Epub 2018 Feb 6.
7
Automated blood glucose control in type 1 diabetes: A review of progress and challenges.1型糖尿病的自动化血糖控制:进展与挑战综述
Endocrinol Diabetes Nutr (Engl Ed). 2018 Mar;65(3):172-181. doi: 10.1016/j.endinu.2017.10.011. Epub 2017 Dec 24.
8
International Consensus on Use of Continuous Glucose Monitoring.连续血糖监测应用的国际共识
Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
9
Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.基于切换控制和动态R参数的双激素人工胰腺系统的经济模型预测控制
J Diabetes Sci Technol. 2017 Nov;11(6):1112-1123. doi: 10.1177/1932296817721519. Epub 2017 Jul 21.
10
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.持续血糖监测:近期研究综述显示血糖结果得到改善
Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37. doi: 10.1089/dia.2017.0035.